"Imidazolidines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds based on reduced IMIDAZOLINES which contain no double bonds in the ring.
Below are MeSH descriptors whose meaning is more general than "Imidazolidines".
Below are MeSH descriptors whose meaning is more specific than "Imidazolidines".
This graph shows the total number of publications written about "Imidazolidines" by people in this website by year, and whether "Imidazolidines" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Imidazolidines" by people in Profiles.
A phase II study of nilutamide in men with prostate cancer after the failure of flutamide or bicalutamide therapy. BJU Int. 2005 Oct; 96(6):787-90.
Ultrahigh resolution drug design. II. Atomic resolution structures of human aldose reductase holoenzyme complexed with Fidarestat and Minalrestat: implications for the binding of cyclic imide inhibitors. Proteins. 2004 Jun 01; 55(4):805-13.
Nilutamide: possible utility as a second-line hormonal agent. Urology. 2001 Dec; 58(6):1016-20.
Clinical studies with an aldose reductase inhibitor in the autonomic and somatic neuropathies of diabetes. Metabolism. 1986 Apr; 35(4 Suppl 1):83-92.
Aldose reductase inhibition improves nerve conduction velocity in diabetic patients. N Engl J Med. 1983 Jan 20; 308(3):119-25.